サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565020

ヘルスケアコールドチェーン物流の世界市場

Healthcare Cold Chain Logistics

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ヘルスケアコールドチェーン物流の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアコールドチェーン物流の世界市場は2030年までに238億米ドルに達する見込み

2023年に182億米ドルと推定されるヘルスケアコールドチェーン物流の世界市場は、分析期間2023-2030年にCAGR 3.9%で成長し、2030年には238億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるワクチンは、CAGR 3.6%を記録し、分析期間終了時には111億米ドルに達すると予測されます。臨床試験材料セグメントの成長率は、分析期間中CAGR 4.1%と推定されます。

米国市場は48億米ドルと推定、中国はCAGR6.0%で成長予測

米国のヘルスケアコールドチェーン物流市場は2023年に48億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR6.0％を追い風に、2030年までに50億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と3.1%と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

世界のヘルスケアコールドチェーン物流市場- 主要動向と促進要因のまとめ

ヘルスケアコールドチェーン物流が温度変化に敏感な製品の完全性を保ち、患者の安全を確保するために不可欠になりつつある理由とは？

ヘルスケアコールドチェーン物流は、ワクチン、生物製剤、医薬品など、温度に敏感な医療製品の完全性を保ち、患者の安全を確保するために不可欠となっています。しかし、なぜ今日のヘルスケアにおいてコールドチェーン・ロジスティクスがこれほど重要なのでしょうか。多くの医療製品、特にワクチン、血液製剤、遺伝子治療関連製品は、温度変動に非常に敏感です。必要な保管条件から逸脱すると、製品の効能を低下させたり、使用に適さなくなったり、腐敗につながったりする可能性があります。これらの製品が患者にとって有効かつ安全であり続けるためには、製造施設から投与時点までのサプライチェーン全体を通して適切な温度を維持することが極めて重要です。

ヘルスケアコールドチェーン物流には、医療製品が特定の温度範囲内で保管され、流通することを確実にするための特殊なプロセス、包装、モニタリング、輸送ソリューションが含まれます。このコールドチェーンは、多くの救命製品、特に予防接種、がん治療、その他の先進医療に使用される製品の安定性と効力を維持するために必要です。生物製剤、個別化医薬品、ワクチンに対する需要の増加に伴い、コールドチェーン・ロジスティクスはヘルスケア業界においてますます重要性を増しており、患者が治療効果を十分に発揮した製品を意図した状態で受け取れるようにしています。

技術の進歩や革新は、ヘルスケアコールドチェーン物流の効率、精度、モニタリングをどのように改善していますか？

技術の進歩により、ヘルスケアコールドチェーン物流の効率性、正確性、モニタリングが大幅に改善され、温度の影響を受けやすい医療製品の輸送や保管の管理が容易になりました。最もインパクトのある技術革新の一つは、リアルタイム温度モニタリングシステムの使用です。これらのシステムは、センサー、GPS、無線通信を採用し、サプライチェーン全体を通して医療製品の温度を継続的に追跡します。製品が必要な範囲外の温度にさらされた場合、システムは即座にアラートを送信し、製品の劣化を防ぐための迅速な是正措置を可能にします。このリアルタイムの可視性により、コールドチェーン物流の信頼性が向上し、製品ロスのリスクが軽減されます。

もうひとつの主な発展は、特定の温度範囲を長期間維持するように設計されたスマート・パッケージング・ソリューションの開発です。こうしたパッケージング・ソリューションには、温度変動から製品を保護するために、相変化材料、真空断熱パネル、その他の先進材料が組み込まれていることが多いです。スマート・パッケージの中には、温度データを監視・記録するデータ・ロガーを装備しているものもあり、製品が輸送中、必要な条件内に保たれていたことを検証可能な形で証明することができます。ヘルスケア製品は安全性と有効性を確保するために温度管理に関する厳格なガイドラインを満たす必要があるため、これは規制遵守のために特に重要です。

ブロックチェーン技術もまた、ヘルスケアコールドチェーン物流の透明性と安全性を向上させる変革的なツールとして台頭してきています。ブロックチェーンは、サプライチェーンを通じた製品のすべての取引と移動を記録する、分散型の改ざん防止台帳の作成を可能にします。この技術により、サプライチェーンに関わるすべての関係者（製造業者、流通業者、物流業者、ヘルスケア施設）が、製品の温度履歴、場所、取り扱いに関する同じ正確な情報にアクセスできるようになります。ブロックチェーンの透明性は、不正のリスクを低減し、規制遵守を確実にし、温度に敏感な製品に検証可能なChain of Custodyを提供することで利害関係者間の信頼を向上させる。

人工知能（AI）と機械学習（ML）もまた、コールドチェーン・ロジスティクスの最適化に果たす役割が高まっています。AIを搭載したシステムは、温度管理、輸送ルート、保管状況に関連する大量のデータを分析し、非効率を特定したり、潜在的な問題を予測したりすることができます。例えば、AIはコールドチェーンに影響を及ぼす可能性のある天候、交通遅延、機器の故障を予測し、リスクを軽減するための代替ルートやソリューションを推奨することができます。機械学習アルゴリズムは、過去のデータから学習することで、これらの予測の精度を継続的に向上させ、ロジスティクス・プロバイダーは、より多くの情報に基づいた意思決定を行い、コールドチェーン・プロセスの信頼性を高めることができます。

コールドチェーン・ロジスティクスにおけるモノのインターネット（IoT）機器の採用も重要な革新です。IoT対応センサーを輸送コンテナ、トラック、保管施設に設置することで、温度、湿度、その他の環境要因をリアルタイムで監視することができます。これらのデバイスは、ヘルスケアプロバイダーに製品の状態を継続的に可視化し、重要な医薬品、ワクチン、生物学的サンプルが適切な温度範囲内で保管されていることを確認することを可能にします。また、IoTソリューションにより、冷蔵機器の予知保全が可能になり、機器の故障リスクを低減し、サプライチェーン全体を通じて製品の安全性を確保することができます。

ヘルスケアコールドチェーン物流が製品の有効性を維持し、廃棄物を削減し、規制要件を満たすために不可欠な理由とは？

ヘルスケアコールドチェーン物流は、製品の有効性を維持し、廃棄物を削減し、規制要件を満たすために不可欠です。なぜなら、温度に敏感な医療製品を最適な状態で保管・輸送することができるからです。コールドチェーン・ロジスティクスの価値が高い主な理由の一つは、医薬品、ワクチン、生物製剤の有効性を維持する役割です。例えば、ワクチンは特定の温度で保管されなければ効果が持続しません。推奨温度範囲外の温度にさらされた場合、効力が失われ、患者が効果のない治療を受ける危険性があります。コールドチェーン・ロジスティクスは、これらの製品が製造時点から投与時点まで治療上の完全性を維持することを保証します。

無駄を省くことも、ヘルスケアコールドチェーン物流の重要な利点です。温度に敏感な製品の不適切な取り扱いや保管は、製品の腐敗による多額の金銭的損失につながる可能性があります。場合によっては、ワクチンや生物製剤が温度逸脱にさらされた証拠があれば、その出荷全体を廃棄しなければならないこともあります。効果的なコールドチェーン管理は、リアルタイムのモニタリング、予測分析、および逸脱が発生した場合に即座に是正措置を講じることができる自動化されたアラートを提供することで、このような事故のリスクを最小限に抑えます。これにより、製品の無駄が削減され、ヘルスケア組織は貴重な医療製品の損失による財務上および経営上の影響を回避することができます。

コールドチェーン・ロジスティクスは、規制要件を満たすためにも不可欠です。米国食品医薬品局（FDA）、欧州医薬品庁（EMA）、世界保健機関（WHO）などの規制機関は、温度に敏感な医療製品の取り扱い、保管、輸送に関する厳格なガイドラインを定めています。これらの規制は、ヘルスケアプロバイダーが製品の安全性と有効性を維持するためのベストプラクティスを遵守することを保証するものです。これらの規制に従わない場合、罰金、罰則、製品回収の対象となることがあります。温度モニタリングとデータロギング技術を備えたコールドチェーン物流システムは、サプライチェーン全体の温度管理に関する検証可能な記録を提供することで、ヘルスケア組織がこれらの規制要件を満たすのに役立ちます。このような記録は、国内および国際規格への準拠を証明するための監査や検査で求められることが多くあります。

ヘルスケアコールドチェーン物流は、患者の安全を確保する上でも重要な役割を果たします。温度に敏感な製品の完全性が損なわれると、患者は最適でない、あるいは安全でない治療にさらされる可能性があります。例えば、腐敗したワクチンは感染症から患者を守ることができず、劣化した生物製剤は副作用や効果のない治療につながる可能性があります。温度条件を厳格に管理することで、コールドチェーン物流システムは患者をこうしたリスクから守り、安全基準を満たした高品質で効果的な治療を受けられるようにします。これは、生物製剤や遺伝子治療が患者の治療に不可欠であり、細心の注意を払って取り扱わなければならないがん治療のような分野では特に重要です。

コールドチェーン・ロジスティクスのもう一つの利点は、特に遠隔地や十分なサービスを受けていない地域における世界ヘルスケアの取り組みを支援できることです。救命のためのワクチンや医薬品の多くは、ヘルスケアのインフラが整っていない地域に届けるために長距離輸送が必要です。コールドチェーン・ロジスティクスは、これらの製品が劣化することなく安全に目的地に到着し、医療従事者が効果的に投与できることを保証します。これは、コールドチェーンの維持がヘルスケアの介入を成功させるために不可欠である、世界の予防接種キャンペーンや公衆衛生上の緊急事態への対応において特に重要です。

ヘルスケアコールドチェーン物流市場の成長を促進する要因とは？

ヘルスケアコールドチェーン物流市場の急成長には、生物製剤や個別化医薬品の需要増加、世界のワクチンキャンペーンの高まり、コールドチェーン技術の進歩、新興市場への医薬品サプライチェーンの拡大など、いくつかの重要な要因があります。主な促進要因の一つは、温度変化に非常に敏感で、正確な保管条件を必要とする生物製剤や個別化医薬品の需要拡大です。モノクローナル抗体、細胞治療、遺伝子治療などの生物製剤は、新薬承認のかなりの部分を占めており、その使用量は今後も増加すると予想されます。これらの製品を輸送・保管するための専門的なコールドチェーン・ロジスティクスの必要性が、市場の成長を後押ししています。

世界のワクチン接種キャンペーンの盛り上がりも、ヘルスケアコールドチェーン物流の拡大に寄与する大きな要因です。COVID-19パンデミックは、世界規模でワクチンを配布するための効率的で信頼性の高いコールドチェーンの重要性を浮き彫りにしました。mRNAワクチンを含むCOVID-19ワクチンの多くは超低温保存を必要とするため、安全な流通にはコールドチェーン・ロジスティクスが不可欠です。世界の保健機関や政府が大規模なワクチン接種キャンペーンを実施し続ける中、遠隔地を含む世界各地へのワクチンの安全な輸送を確保できるコールドチェーン・ロジスティクス・ソリューションに対する需要は拡大すると予想されます。

リアルタイム監視システム、スマートパッケージング、IoT対応センサーなど、コールドチェーン技術の先進化も市場の成長を後押ししています。これらの技術革新により、ヘルスケアプロバイダーは、サプライチェーン全体を通じて、温度に敏感な製品の追跡と維持が容易になります。リアルタイムのデータロギングとアラートにより、組織は輸送中や保管中に発生した問題に迅速に対処でき、製品の腐敗リスクを低減できます。こうした先進技術の採用が進むにつれ、コールドチェーン・ロジスティクスの効率と信頼性が向上し、製薬会社やヘルスケア組織にとってますます魅力的なソリューションとなっています。

新興市場への医薬品サプライチェーンの拡大も、ヘルスケアコールドチェーン物流分野の成長の重要な促進要因です。製薬会社は発展を目指す中で、温度に敏感な製品を長距離輸送するという課題に直面しており、インフラが不十分な地域を経由することも少なくありません。コールドチェーン・ロジスティクス・プロバイダーは、これらの製品が品質や安全性を損なうことなく目的地に到達できるよう、ネットワークや能力を拡大しています。製薬企業が新興市場で存在感を高め続けていることから、複雑な国際物流環境に対応できるコールドチェーン・ソリューションに対する需要は高まると予想されます。

規制圧力もヘルスケアコールドチェーン物流市場の成長に寄与しています。世界中の規制機関が温度変化に敏感な製品の保管・輸送に関するガイドラインを厳格化する中、ヘルスケア企業はこうした厳しい要件を満たすことができるコールドチェーンシステムに投資する必要があります。規制遵守は、患者の安全を確保するだけでなく、罰金や罰則、製品リコールを回避するためにも不可欠です。進化する規制を遵守する必要性から、ヘルスケアプロバイダーや製薬会社は、より高度で信頼性の高いコールドチェーン・ロジスティクス・ソリューションの導入を促しています。

結論として、ヘルスケアコールドチェーン物流市場の成長は、生物製剤の需要増加、世界のワクチン接種キャンペーン、コールドチェーン技術の進歩、新興市場への医薬品サプライチェーンの拡大が原動力となっています。ヘルスケア機関が温度変化に敏感な製品の完全性を維持するという課題に直面するなか、コールドチェーン・ロジスティクスは製品の安全性、規制遵守、効果的な患者ケアを確保する上で不可欠な役割を果たすでしょう。

調査対象企業の例（注目の44社）

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne+Nagel International AG
  • Marken Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12289

Global Healthcare Cold Chain Logistics Market to Reach US$23.8 Billion by 2030

The global market for Healthcare Cold Chain Logistics estimated at US$18.2 Billion in the year 2023, is expected to reach US$23.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Clinical Trial Materials segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 6.0% CAGR

The Healthcare Cold Chain Logistics market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Healthcare Cold Chain Logistics Market - Key Trends and Drivers Summarized

Why Is Healthcare Cold Chain Logistics Becoming Essential for Preserving the Integrity of Temperature-Sensitive Products and Ensuring Patient Safety?

Healthcare cold chain logistics has become essential for preserving the integrity of temperature-sensitive medical products, such as vaccines, biologics, and pharmaceuticals, while ensuring patient safety. But why is cold chain logistics so critical in healthcare today? Many medical products, especially those related to vaccines, blood products, and gene therapies, are highly sensitive to temperature fluctuations. Any deviation from the required storage conditions can degrade the product’s efficacy, render it unsafe for use, or lead to spoilage, which could result in adverse patient outcomes or substantial financial losses. Maintaining the correct temperature throughout the entire supply chain—from manufacturing facilities to the point of administration—is crucial to ensuring that these products remain effective and safe for patients.

Healthcare cold chain logistics involves specialized processes, packaging, monitoring, and transportation solutions to ensure that medical products are stored and distributed within a specific temperature range. This cold chain is necessary for maintaining the stability and potency of many life-saving products, especially those used in immunizations, cancer treatments, and other advanced medical therapies. With the increase in demand for biologics, personalized medicines, and vaccines, cold chain logistics is becoming increasingly critical in the healthcare industry, ensuring that patients receive products in their intended condition, with full therapeutic efficacy.

How Are Technological Advancements and Innovations Improving the Efficiency, Accuracy, and Monitoring of Healthcare Cold Chain Logistics?

Technological advancements are significantly improving the efficiency, accuracy, and monitoring of healthcare cold chain logistics, making it easier to manage the transportation and storage of temperature-sensitive medical products. One of the most impactful innovations is the use of real-time temperature monitoring systems. These systems employ sensors, GPS, and wireless communication to continuously track the temperature of medical products throughout the supply chain. If a product is exposed to temperatures outside its required range, the system sends an instant alert, allowing for immediate corrective actions to prevent product degradation. This real-time visibility enhances the reliability of cold chain logistics and reduces the risk of product loss.

Another key advancement is the development of smart packaging solutions, which are designed to maintain specific temperature ranges for extended periods. These packaging solutions often incorporate phase-change materials, vacuum insulation panels, and other advanced materials to protect products from temperature fluctuations. Some smart packages are equipped with data loggers that monitor and record temperature data, providing verifiable proof that the product has remained within the required conditions throughout its journey. This is particularly important for regulatory compliance, as healthcare products must meet strict guidelines for temperature control to ensure their safety and effectiveness.

Blockchain technology is also emerging as a transformative tool for improving the transparency and security of healthcare cold chain logistics. Blockchain enables the creation of a decentralized, tamper-proof ledger that records every transaction and movement of a product through the supply chain. This technology ensures that all parties involved in the supply chain—manufacturers, distributors, logistics providers, and healthcare facilities—have access to the same accurate information regarding the product’s temperature history, location, and handling. Blockchain’s transparency reduces the risk of fraud, ensures regulatory compliance, and improves trust between stakeholders by providing a verifiable chain of custody for temperature-sensitive products.

Artificial intelligence (AI) and machine learning (ML) are also playing a growing role in optimizing cold chain logistics. AI-powered systems can analyze large volumes of data related to temperature control, transportation routes, and storage conditions to identify inefficiencies and predict potential issues. For example, AI can forecast weather conditions, traffic delays, or equipment failures that might impact the cold chain and recommend alternative routes or solutions to mitigate risks. Machine learning algorithms continuously improve the accuracy of these predictions by learning from historical data, allowing logistics providers to make more informed decisions and enhance the reliability of cold chain processes.

The adoption of Internet of Things (IoT) devices in cold chain logistics is another significant innovation. IoT-enabled sensors can be placed in shipping containers, trucks, and storage facilities to monitor temperature, humidity, and other environmental factors in real time. These devices provide healthcare providers with continuous visibility into the condition of their products, allowing them to ensure that critical medicines, vaccines, or biological samples are stored within the correct temperature range. IoT solutions also allow for predictive maintenance of refrigeration equipment, reducing the risk of equipment failure and ensuring that products remain safe throughout the supply chain.

Why Is Healthcare Cold Chain Logistics Critical for Maintaining Product Efficacy, Reducing Waste, and Meeting Regulatory Requirements?

Healthcare cold chain logistics is critical for maintaining product efficacy, reducing waste, and meeting regulatory requirements because it ensures that temperature-sensitive medical products are stored and transported under optimal conditions. One of the main reasons cold chain logistics is so valuable is its role in preserving the efficacy of pharmaceuticals, vaccines, and biologics, many of which are sensitive to temperature fluctuations. For example, vaccines must be stored at specific temperatures to remain effective. If they are exposed to temperatures outside their recommended range, they may lose potency, putting patients at risk of receiving ineffective treatments. Cold chain logistics ensures that these products maintain their therapeutic integrity from the point of manufacture to the point of administration.

Reducing waste is another critical benefit of healthcare cold chain logistics. The improper handling or storage of temperature-sensitive products can lead to significant financial losses due to product spoilage. In some cases, entire shipments of vaccines or biologics may need to be discarded if there is evidence that they were exposed to temperature excursions. Effective cold chain management minimizes the risk of such incidents by providing real-time monitoring, predictive analytics, and automated alerts that allow for immediate corrective actions when deviations occur. This reduces product waste and helps healthcare organizations avoid the financial and operational consequences of losing valuable medical products.

Cold chain logistics is also essential for meeting regulatory requirements. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO) have established strict guidelines for the handling, storage, and transportation of temperature-sensitive medical products. These regulations ensure that healthcare providers adhere to best practices for maintaining product safety and efficacy. Failure to comply with these regulations can result in fines, penalties, or product recalls. Cold chain logistics systems, equipped with temperature monitoring and data logging technologies, help healthcare organizations meet these regulatory requirements by providing verifiable records of temperature control throughout the supply chain. These records are often required during audits and inspections to demonstrate compliance with national and international standards.

Healthcare cold chain logistics also plays a critical role in ensuring patient safety. When the integrity of temperature-sensitive products is compromised, patients may be exposed to suboptimal or unsafe treatments. For example, spoiled vaccines may fail to protect individuals from infectious diseases, while degraded biologics may lead to adverse reactions or ineffective therapies. By maintaining strict control over temperature conditions, cold chain logistics systems protect patients from these risks, ensuring that they receive high-quality, effective treatments that meet safety standards. This is particularly important in areas like cancer treatment, where biologics and gene therapies are essential for patient care and must be handled with extreme care.

Another benefit of cold chain logistics is its ability to support global healthcare efforts, particularly in remote or underserved regions. Many life-saving vaccines and medicines must be transported across long distances to reach areas with limited healthcare infrastructure. Cold chain logistics ensures that these products can safely reach their destination without degradation, enabling healthcare providers to administer them effectively. This is especially crucial during global vaccination campaigns or responses to public health emergencies, where maintaining the cold chain is essential for the success of healthcare interventions.

What Factors Are Driving the Growth of the Healthcare Cold Chain Logistics Market?

Several key factors are driving the rapid growth of the healthcare cold chain logistics market, including the increasing demand for biologics and personalized medicines, the rise of global vaccination campaigns, advancements in cold chain technologies, and the expansion of pharmaceutical supply chains into emerging markets. One of the primary drivers is the growing demand for biologics and personalized medicines, which are highly sensitive to temperature variations and require precise storage conditions. Biologics, such as monoclonal antibodies, cell therapies, and gene therapies, represent a significant portion of new drug approvals, and their use is expected to continue rising. The need for specialized cold chain logistics to transport and store these products is fueling the growth of the market.

The rise of global vaccination campaigns is another significant factor contributing to the expansion of healthcare cold chain logistics. The COVID-19 pandemic highlighted the importance of an efficient and reliable cold chain for distributing vaccines on a global scale. Many COVID-19 vaccines, including mRNA vaccines, require ultra-low temperature storage, making cold chain logistics essential for their safe distribution. As global health organizations and governments continue to implement large-scale vaccination campaigns, the demand for cold chain logistics solutions that can ensure the safe transport of vaccines to all parts of the world, including remote regions, is expected to grow.

Advancements in cold chain technologies, such as real-time monitoring systems, smart packaging, and IoT-enabled sensors, are also driving the growth of the market. These innovations make it easier for healthcare providers to track and maintain temperature-sensitive products throughout the supply chain. Real-time data logging and alerts enable organizations to quickly address any issues that arise during transportation or storage, reducing the risk of product spoilage. The growing adoption of these advanced technologies is improving the efficiency and reliability of cold chain logistics, making it an increasingly attractive solution for pharmaceutical companies and healthcare organizations.

The expansion of pharmaceutical supply chains into emerging markets is another key driver of growth in the healthcare cold chain logistics sector. As pharmaceutical companies seek to reach new markets in developing regions, they face the challenge of transporting temperature-sensitive products across long distances, often through regions with inadequate infrastructure. Cold chain logistics providers are expanding their networks and capabilities to ensure that these products can reach their destination without compromising quality or safety. The demand for cold chain solutions that can navigate complex international logistics environments is expected to increase as pharmaceutical companies continue to grow their presence in emerging markets.

Regulatory pressure is also contributing to the growth of the healthcare cold chain logistics market. As regulatory agencies around the world tighten guidelines for the storage and transportation of temperature-sensitive products, healthcare organizations must invest in cold chain systems that can meet these stringent requirements. Regulatory compliance is essential not only for ensuring patient safety but also for avoiding fines, penalties, or product recalls. The need to comply with evolving regulations is prompting healthcare providers and pharmaceutical companies to adopt more advanced and reliable cold chain logistics solutions.

In conclusion, the growth of the healthcare cold chain logistics market is driven by increasing demand for biologics, global vaccination campaigns, advancements in cold chain technologies, and the expansion of pharmaceutical supply chains into emerging markets. As healthcare organizations face the growing challenge of maintaining the integrity of temperature-sensitive products, cold chain logistics will play an essential role in ensuring product safety, regulatory compliance, and effective patient care.

Select Competitors (Total 44 Featured) -

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Healthcare Cold Chain Logistics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Temperature-sensitive Pharmaceuticals Drives Growth in Healthcare Cold Chain Logistics
    • Expansion of Biologics, Vaccines, and Biosimilars Fuels Demand for Cold Chain Solutions
    • Role of Cold Chain Logistics in Ensuring Drug Safety and Efficacy Throughout Distribution
    • Technological Advancements in IoT and Sensor-based Monitoring Enhance Cold Chain Logistics
    • Role of Cold Chain Logistics in Reducing Pharmaceutical Waste and Expiry
    • Expansion of Cold Chain Infrastructure in Emerging Markets to Support Global Vaccine Distribution
    • Role of Blockchain in Enhancing Transparency and Traceability in Healthcare Cold Chain Logistics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Healthcare Cold Chain Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Clinical Trial Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • JAPAN
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • CHINA
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • EUROPE
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • FRANCE
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • GERMANY
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • INDIA
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • AFRICA
    • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030

IV. COMPETITION